Analysis of Factors Influencing Multidrug-Resistant Tuberculosis and Validation of Whole-Genome Sequencing in Children with Drug-Resistant Tuberculosis

References

• Furin J. Advances in the diagnosis, treatment, and prevention of tuberculosis in children. Expert Rev Respir Med. 2019;13(3):301–311. doi:10.1080/17476348.2019.156951830648437
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization; 2020.
   Google Scholar
• Jenkins HE, Yuen CM. The burden of multidrug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2018;22(5):3–6. doi:10.5588/ijtld.17.0357
   PubMed Web of Science ®Google Scholar
• Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA. Treatment of multidrug-resistant tuberculosis infection in children. Pediatr Infect Dis J. 2018;37(10):1061–1064. doi:10.1097/INF.000000000000213530216296
   PubMed Web of Science ®Google Scholar
• Dunn JJ, Starke JR, Revell PA. Laboratory diagnosis of Mycobacterium tuberculosis infection and disease in children. J Clin Microbiol. 2016;54(6):1434–1441. doi:10.1128/JCM.03043-1526984977
   PubMed Web of Science ®Google Scholar
• Yang R, Liu M, Jiang H, et al. The epidemiology of pulmonary tuberculosis in children in Mainland China, 2009–2015. Arch Dis Child. 2020;105(4):319–325. doi:10.1136/archdischild-2019-31763531771943
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rapid communication: molecular assays as initial tests for the diagnosis of tuberculosis and rifampicin resistance. Geneva: World Health Organization; 2020.
   Google Scholar
• Kay AW, Gonzalez Fernandez L, Takwoingi Y, et al. Xpert MTB/RIF and xpert MTB/RIF ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020;8:CD013359.32853411
   PubMed Web of Science ®Google Scholar
• Jenkins HE, Yuen CM, Rodriguez CA, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285–295. doi:10.1016/S1473-3099(16)30474-127964822
   PubMed Web of Science ®Google Scholar
• Gygli SM, Keller PM, Ballif M, et al. Whole-genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2019;63(4). doi:10.1128/AAC.02175-18
   PubMed Web of Science ®Google Scholar
• Zhao Yan Lin PY. The test procedures of tuberculosis diagnostic laboratory. People’s Medical Publishing House. 2015:1–127.
   Google Scholar
• World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva; 2014.
   Google Scholar
• Otchere ID, Asante-Poku A, Osei-Wusu S, et al. Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: a prospective study in two distant regions of Ghana. Tuberculosis. 2016;99:147–154. doi:10.1016/j.tube.2016.05.01427450017
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884–i890. doi:10.1093/bioinformatics/bty56030423086
   PubMed Web of Science ®Google Scholar
• Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. arXiv Preprint arXiv 1207 3907; 2012.
   Google Scholar
• Wiseman CA, Gie RP, Starke JR, et al. A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J. 2012;31(4):347–352. doi:10.1097/INF.0b013e318243e27b22315002
   PubMed Web of Science ®Google Scholar
• Avaliani Z, Gozalov O, Kuchukhidze G, et al. What is behind programmatic treatment outcome definitions for tuberculosis? Eur Respir J. 2020;56(1):2001751. doi:10.1183/13993003.01751-202032703821
   PubMed Web of Science ®Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–282. doi:10.11613/BM.2012.031
   PubMed Web of Science ®Google Scholar
• Doyle RM, Burgess C, Williams R, et al. Direct whole-genome sequencing of sputum accurately identifies drug-resistant Mycobacterium tuberculosis faster than MGIT culture sequencing. J Clin Microbiol. 2018;56(8). doi:10.1128/JCM.00666-18
   Web of Science ®Google Scholar
• Votintseva AA, Bradley P, Pankhurst L, et al. Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples. J Clin Microbiol. 2017;55(5):1285–1298. doi:10.1128/JCM.02483-1628275074
   PubMed Web of Science ®Google Scholar
• Mok S, Roycroft E, Flanagan PR, et al. Overcoming the challenges of pyrazinamide susceptibility testing in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother. 2021;65(8). doi:10.1128/AAC.02617-20
   Web of Science ®Google Scholar
• Papaventsis D, Casali N, Kontsevaya I, Drobniewski F, Cirillo DM, Nikolayevskyy V. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review. Clin Microbiol Infect. 2017;23(2):61–68. doi:10.1016/j.cmi.2016.09.00827665704
   PubMed Web of Science ®Google Scholar
• Walker TM, Kohl TA, Omar SV, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis. 2015;15(10):1193–1202. doi:10.1016/S1473-3099(15)00062-626116186
   PubMed Web of Science ®Google Scholar
• Ektefaie Y, Dixit A, Freschi L, Farhat MR. Globally diverse Mycobacterium tuberculosis resistance acquisition: a retrospective geographical and temporal analysis of whole genome sequences. Lancet Microbe. 2021;2(3):e96–e104. doi:10.1016/S2666-5247(20)30195-633912853
   PubMedGoogle Scholar
• Lu Z, Jiang W, Zhang J, et al. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China. PLoS One. 2019;14(11):e0225361. doi:10.1371/journal.pone.022536131751390
   PubMed Web of Science ®Google Scholar
• Ngo TM, Teo YY. Genomic prediction of tuberculosis drug-resistance: benchmarking existing databases and prediction algorithms. BMC Bioinform. 2019;20(1):68. doi:10.1186/s12859-019-2658-z
   Web of Science ®Google Scholar
• Huo F, Lu J, Zong Z, et al. Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China. BMC Infect Dis. 2019;19(1):689. doi:10.1186/s12879-019-4333-431382930
   PubMed Web of Science ®Google Scholar
• Manson AL, Cohen KA, Abeel T, et al. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat Genet. 2017;49(3):395–402. doi:10.1038/ng.376728092681
   PubMed Web of Science ®Google Scholar
• Anwaierjiang A, Wang Q, Liu H, et al. Prevalence and molecular characteristics based on whole genome sequencing of Mycobacterium tuberculosis resistant to four anti-tuberculosis drugs from Southern Xinjiang, China. Infect Drug Resist. 2021;14:3379–3391. doi:10.2147/IDR.S32002434466004
   PubMed Web of Science ®Google Scholar
• Hicks ND, Carey AF, Yang J, Zhao Y, Fortune SM. Bacterial genome-wide association identifies novel factors that contribute to ethionamide and prothionamide susceptibility in Mycobacterium tuberculosis. MBio. 2019;10(2):e00616–e00619.31015328
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar S, Saleem A, Thirumal Kumar D, et al. A systemic approach to explore the mechanisms of drug resistance and altered signaling cascades in extensively drug-resistant tuberculosis. Adv Protein Chem Struct Biol. 2021;127:343–364.34340773
   PubMed Web of Science ®Google Scholar
• Ma P, Luo T, Ge L, et al. Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region. Emerg Microbes Infect. 2021;10(1):743–752. doi:10.1080/22221751.2021.190809633775224
   PubMed Web of Science ®Google Scholar
• Wu X, Gao R, Shen X, et al. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China. Int J Infect Dis. 2020;96:48–53. doi:10.1016/j.ijid.2020.04.03932339720
   PubMed Web of Science ®Google Scholar
• Maruri F, Guo Y, Blackman A, van der Heijden YF, Rebeiro PF, Sterling TR. Resistance-conferring mutations on whole-genome sequencing of fluoroquinolone-resistant and -susceptible Mycobacterium tuberculosis isolates: a proposed threshold for identifying resistance. Clin Infect Dis. 2021;72(11):1910–1918. doi:10.1093/cid/ciaa49632348473
   PubMed Web of Science ®Google Scholar
• Hameed HMA, Tan Y, Islam MM, et al. Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China. J Thorac Dis. 2019;11(11):4613–4625. doi:10.21037/jtd.2019.11.0331903250
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Kim H, Mukai T, Matsuoka M, Nakajima C, Suzuki Y. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance. PLoS Negl Trop Dis. 2012;6(10):e1838. doi:10.1371/journal.pntd.000183823071850
   PubMed Web of Science ®Google Scholar
• Momen G, Aainouss A, Lamaammal A, et al. Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco. Rev Inst Med Trop Sao Paulo. 2021;63:e19. doi:10.1590/s1678-994620216301933787739
   PubMed Web of Science ®Google Scholar
• Parr JB, Mitnick CD, Atwood SS, Chalco K, Bayona J, Becerra MC. Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2014;58(3):392–395. doi:10.1093/cid/cit70924170196
   PubMed Web of Science ®Google Scholar
• Barbier M, Wirth T. The evolutionary history, demography, and spread of the Mycobacterium tuberculosis complex. Microbiol Spectr. 2016;4:4. doi:10.1128/microbiolspec.TBTB2-0008-2016
   Web of Science ®Google Scholar
• Huang H, Ding N, Yang T, et al. Cross-sectional whole-genome sequencing and epidemiological study of multidrug-resistant Mycobacterium tuberculosis in China. Clin Infect Dis. 2019;69(3):405–413. doi:10.1093/cid/ciy88330321294
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang Y, Liu Z, et al. Associations between Mycobacterium tuberculosis Beijing genotype and drug resistance to four first-line drugs: a survey in China. Front Med. 2018;12(1):92–97. doi:10.1007/s11684-017-0610-z29288283
   PubMed Web of Science ®Google Scholar
• Zhao LL, Li MC, Liu HC, et al. Beijing genotype of Mycobacterium tuberculosis is less associated with drug resistance in south China. Int J Antimicrob Agents. 2019;54(6):766–770. doi:10.1016/j.ijantimicag.2019.08.00531398482
   PubMed Web of Science ®Google Scholar
• Karmakar M, Trauer JM, Ascher DB, Denholm JT. Hyper transmission of Beijing lineage Mycobacterium tuberculosis: systematic review and meta-analysis. J Infect. 2019;79(6):572–581. doi:10.1016/j.jinf.2019.09.01631585190
   PubMed Web of Science ®Google Scholar
• Yang C, Lu L, Warren JL, et al. Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. Lancet Infect Dis. 2018;18(7):788–795. doi:10.1016/S1473-3099(18)30218-429681517
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Q, Zhu M, et al. The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015–2018: a retrospective study. Medicine. 2020;99(43):e22608. doi:10.1097/MD.000000000002260833120748
   PubMed Web of Science ®Google Scholar
• Khatami A, Britton PN, Marais BJ. Management of children with tuberculosis. Clin Chest Med. 2019;40(4):797–810. doi:10.1016/j.ccm.2019.08.00331731985
   PubMed Web of Science ®Google Scholar
• Gan M, Liu Q, Yang C, Gao Q, Luo T. Deep whole-genome sequencing to detect mixed infection of Mycobacterium tuberculosis. PLoS One. 2016;11(7):e0159029. doi:10.1371/journal.pone.015902927391214
   PubMed Web of Science ®Google Scholar